BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 7973659)

  • 21. Identification of a variable region within the cytoplasmic tail of the IL-2 receptor beta chain that is required for growth signal transduction.
    Liu KD; Lai SY; Goldsmith MA; Greene WC
    J Biol Chem; 1995 Sep; 270(38):22176-81. PubMed ID: 7545674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IL-2 receptor signaling through the Shb adapter protein in T and NK cells.
    Lindholm CK
    Biochem Biophys Res Commun; 2002 Aug; 296(4):929-36. PubMed ID: 12200137
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correction of interleukin-2 receptor function in X-SCID lymphoblastoid cells by retrovirally mediated transfer of the gamma-c gene.
    Taylor N; Uribe L; Smith S; Jahn T; Kohn DB; Weinberg K
    Blood; 1996 Apr; 87(8):3103-7. PubMed ID: 8605323
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Jeg-3 human choriocarcinoma-induced immunosuppression: downregulation of interleukin-2, interleukin-2 receptor alpha-chain, and its Jak/Stat signaling pathway.
    Kilic M; Flossmann E; Flossmann O; Vogelsang H; Junker U; Chaouat G; Markert UR
    Am J Reprod Immunol; 1999 Jan; 41(1):61-9. PubMed ID: 10097788
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activation of JAK3, but not JAK1, is critical to interleukin-4 (IL4) stimulated proliferation and requires a membrane-proximal region of IL4 receptor alpha.
    Malabarba MG; Kirken RA; Rui H; Koettnitz K; Kawamura M; O'Shea JJ; Kalthoff FS; Farrar WL
    J Biol Chem; 1995 Apr; 270(16):9630-7. PubMed ID: 7721895
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interleukin-2 induces tyrosine phosphorylation of SHP-2 through IL-2 receptor beta chain.
    Adachi M; Ishino M; Torigoe T; Minami Y; Matozaki T; Miyazaki T; Taniguchi T; Hinoda Y; Imai K
    Oncogene; 1997 Apr; 14(13):1629-33. PubMed ID: 9129156
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interleukin 12 (IL-12) induces tyrosine phosphorylation of JAK2 and TYK2: differential use of Janus family tyrosine kinases by IL-2 and IL-12.
    Bacon CM; McVicar DW; Ortaldo JR; Rees RC; O'Shea JJ; Johnston JA
    J Exp Med; 1995 Jan; 181(1):399-404. PubMed ID: 7528775
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Signaling via IL-2 and IL-4 in JAK3-deficient severe combined immunodeficiency lymphocytes: JAK3-dependent and independent pathways.
    Oakes SA; Candotti F; Johnston JA; Chen YQ; Ryan JJ; Taylor N; Liu X; Hennighausen L; Notarangelo LD; Paul WE; Blaese RM; O'Shea JJ
    Immunity; 1996 Dec; 5(6):605-15. PubMed ID: 8986719
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protein tyrosine kinase Syk is associated with and activated by the IL-2 receptor: possible link with the c-myc induction pathway.
    Minami Y; Nakagawa Y; Kawahara A; Miyazaki T; Sada K; Yamamura H; Taniguchi T
    Immunity; 1995 Jan; 2(1):89-100. PubMed ID: 7600304
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Human lung myofibroblasts as effectors of the inflammatory process: the common receptor gamma chain is induced by Th2 cytokines, and CD40 ligand is induced by lipopolysaccharide, thrombin and TNF-alpha.
    Doucet C; Giron-Michel J; Canonica GW; Azzarone B
    Eur J Immunol; 2002 Sep; 32(9):2437-49. PubMed ID: 12207328
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of Jak/STAT proteins involved in signal transduction pathway mediated by receptor for interleukin 2 in malignant T lymphocytes derived from cutaneous anaplastic large T-cell lymphoma and Sezary syndrome.
    Zhang Q; Nowak I; Vonderheid EC; Rook AH; Kadin ME; Nowell PC; Shaw LM; Wasik MA
    Proc Natl Acad Sci U S A; 1996 Aug; 93(17):9148-53. PubMed ID: 8799169
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autosomal SCID caused by a point mutation in the N-terminus of Jak3: mapping of the Jak3-receptor interaction domain.
    Cacalano NA; Migone TS; Bazan F; Hanson EP; Chen M; Candotti F; O'Shea JJ; Johnston JA
    EMBO J; 1999 Mar; 18(6):1549-58. PubMed ID: 10075926
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hierarchy of protein tyrosine kinases in interleukin-2 (IL-2) signaling: activation of syk depends on Jak3; however, neither Syk nor Lck is required for IL-2-mediated STAT activation.
    Zhou YJ; Magnuson KS; Cheng TP; Gadina M; Frucht DM; Galon J; Candotti F; Geahlen RL; Changelian PS; O'Shea JJ
    Mol Cell Biol; 2000 Jun; 20(12):4371-80. PubMed ID: 10825200
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pyk2 is a downstream mediator of the IL-2 receptor-coupled Jak signaling pathway.
    Miyazaki T; Takaoka A; Nogueira L; Dikic I; Fujii H; Tsujino S; Mitani Y; Maeda M; Schlessinger J; Taniguchi T
    Genes Dev; 1998 Mar; 12(6):770-5. PubMed ID: 9512511
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Similarities and differences in signal transduction by interleukin 4 and interleukin 13: analysis of Janus kinase activation.
    Keegan AD; Johnston JA; Tortolani PJ; McReynolds LJ; Kinzer C; O'Shea JJ; Paul WE
    Proc Natl Acad Sci U S A; 1995 Aug; 92(17):7681-5. PubMed ID: 7544000
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Concomitant inhibition of Janus kinase 3 and calcineurin-dependent signaling pathways synergistically prolongs the survival of rat heart allografts.
    Behbod F; Erwin-Cohen RA; Wang ME; Trawick BW; Qu X; Verani R; Kahan BD; Stepkowski SM; Kirken RA
    J Immunol; 2001 Mar; 166(6):3724-32. PubMed ID: 11238613
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tumor-induced suppression of T lymphocyte proliferation coincides with inhibition of Jak3 expression and IL-2 receptor signaling: role of soluble products from human renal cell carcinomas.
    Kolenko V; Wang Q; Riedy MC; O'Shea J; Ritz J; Cathcart MK; Rayman P; Tubbs R; Edinger M; Novick A; Bukowski R; Finke J
    J Immunol; 1997 Sep; 159(6):3057-67. PubMed ID: 9300731
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interleukin-4-specific signal transduction events are driven by homotypic interactions of the interleukin-4 receptor alpha subunit.
    Lai SY; Molden J; Liu KD; Puck JM; White MD; Goldsmith MA
    EMBO J; 1996 Sep; 15(17):4506-14. PubMed ID: 8887542
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Downregulation of JAK3 protein levels in T lymphocytes by prostaglandin E2 and other cyclic adenosine monophosphate-elevating agents: impact on interleukin-2 receptor signaling pathway.
    Kolenko V; Rayman P; Roy B; Cathcart MK; O'Shea J; Tubbs R; Rybicki L; Bukowski R; Finke J
    Blood; 1999 Apr; 93(7):2308-18. PubMed ID: 10090941
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The serine-rich cytoplasmic domain of the interleukin-2 receptor beta chain is essential for interleukin-2-dependent tyrosine protein kinase and phosphatidylinositol-3-kinase activation.
    Merida I; Williamson P; Kuziel WA; Greene WC; Gaulton GN
    J Biol Chem; 1993 Mar; 268(9):6765-70. PubMed ID: 8384218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.